I don't know that they'll achieve that type of Utopian success. OTC companies generally do not. What I continue to like about the company is the transparency provided by the CEO. She scaffolds her communication well with 8Ks followed by PRs. That psychological comfort level will drive PPS as much as numbers in a typically momentum driven OTC. Right now it seems BMXC is being heavily manipulated and with the bashing attack happening over at IHUB, sentiment turned south. Ultimately, I like the chances of this moving stronger on momentum returning when all of the deals you mentioned start to hit. At the moment though, the trend is down.